|Articles|January 10, 2017
Cancer Research UK Joins ACRP Standards Group
Author(s)Philip Ward
Cancer Research UK has become a member of the Workforce Development Steering Committee of the Association of Clinical Research Professionals (ACRP).
Advertisement
Cancer Research UK has become a member of the Workforce Development Steering Committee of the Association of Clinical Research Professionals (ACRP).
The group’s main goal is to review and approve core competence standards for clinical research professionals. Its members comprise industry and academic organizations across the global clinical research sector.
"Cancer Research UK has long supported the training and development of the next generation of clinical research professionals," says Dr. Nigel Blackburn, Cancer Research UK's director of drug development. "We're really pleased that we now have the opportunity to contribute to this international collaboration led by ACRP which will help to maintain a high quality in clinical research across the globe."
As its first initiative, the committee will request public comment on a competence framework for clinical research associates (CRAs). This framework will define standards for clinical trial monitors/CRAs within the eight core competence domains for clinical research professionals, as defined by the Joint Task Force for Clinical Trial Competence.
"ACRP is excited to announce Cancer Research UK as a member of the ACRP Workforce Development Steering Committee," says Terri Hinkley, RN, BScN, MBA, CCRC, FACRP, ACRP's Workforce Innovation Officer. "We are thankful for Cancer Research UK's willingness to support workforce competence standardization as a means of promoting excellence in clinical research.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
2
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
3
eClinical Technology: Misconceptions, Challenges, and Opportunities
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5